Enveric Biosciences, Inc.

Biotechnology • Healthcare • Cambridge, MA, United States • ENVB (NCM)

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Enveric Biosciences Inc. (ENVB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

StocksToTrade • Dec 31

Enveric Biosciences announces issuance of U.S. patent - Yahoo Finance

Yahoo Finance • Dec 30

Enveric Biosciences (ENVB) Price Target Increased by 1,100.00% to 122.40 - Nasdaq

Nasdaq • Oct 29

Enveric Biosciences Announces Reverse Stock Split - Business Wire

Business Wire • Oct 23

Enveric Biosciences stock rises after securing patent for novel neurological treatments - Investing.com

Investing.com • Dec 29

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Enveric Biosciences, Inc. had layoffs?

No layoff events have been recorded for Enveric Biosciences, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Enveric Biosciences, Inc. have?

Enveric Biosciences, Inc. has approximately 5 employees.

What industry is Enveric Biosciences, Inc. in?

Enveric Biosciences, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Enveric Biosciences, Inc. a publicly traded company?

Yes, Enveric Biosciences, Inc. is publicly traded under the ticker symbol ENVB on the NCM. The company has a market capitalization of approximately $0.00 billion.

Where is Enveric Biosciences, Inc. headquartered?

Enveric Biosciences, Inc. is headquartered in Cambridge, MA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.